{"id":834909,"date":"2022-11-15T18:00:16","date_gmt":"2022-11-15T17:00:16","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/"},"modified":"2022-11-15T18:00:16","modified_gmt":"2022-11-15T17:00:16","slug":"frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/","title":{"rendered":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V."},"content":{"rendered":"MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (\u201cFLAC\u201d), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its shareholders voted to approve the proposed business combination (the \u201cBusiness Combination\u201d) with NewAmsterdam Pharma Holding B.V. (\u201cNewAmsterdam\u201d), a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases.\n\n\nMore than 90% of the votes cast at the Extraordinary General Meeting of Shareholders (the \u201cGeneral Meeting\u201d) were cast in favor of the previously announced business combination. FLAC shareholders also voted to approv<div class=\"leaky_paywall_message_wrap\"><div id=\"leaky_paywall_message\"><a href=\"https:\/\/bebeez.it\/abbonati\/\">Abbonati<\/a> o <a href=\"https:\/\/bebeez.it\/mio-account\/\">Accedi<\/a> per leggere il resto di questo contenuto.<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>MENLO PARK, Calif.&#8211;(BUSINESS WIRE)&#8211;Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (\u201cFLAC\u201d), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its shareholders voted to approve the proposed business combination (the \u201cBusiness Combination\u201d) with NewAmsterdam Pharma Holding B.V. (\u201cNewAmsterdam\u201d), a late clinical-stage company focused on the research and development of [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49625],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-834909","post","type-post","status-publish","format-standard","hentry","category-private-capital-in-north-america"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (\u201cFLAC\u201d), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its shareholders voted to approve the proposed business combination (the \u201cBusiness Combination\u201d) with NewAmsterdam Pharma Holding B.V. (\u201cNewAmsterdam\u201d), a late clinical-stage company focused on the research and development of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-15T17:00:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.\",\"datePublished\":\"2022-11-15T17:00:16+00:00\",\"dateModified\":\"2022-11-15T17:00:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\"},\"wordCount\":1805,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Private capital in North America\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\",\"url\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\",\"name\":\"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-11-15T17:00:16+00:00\",\"dateModified\":\"2022-11-15T17:00:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/","og_locale":"en_US","og_type":"article","og_title":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez","og_description":"MENLO PARK, Calif.--(BUSINESS WIRE)--Frazier Lifesciences Acquisition Corporation (Nasdaq: FLAC) (\u201cFLAC\u201d), a special purpose acquisition company sponsored by an affiliate of Frazier Healthcare Partners, announced today that its shareholders voted to approve the proposed business combination (the \u201cBusiness Combination\u201d) with NewAmsterdam Pharma Holding B.V. (\u201cNewAmsterdam\u201d), a late clinical-stage company focused on the research and development of [&hellip;]","og_url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/","og_site_name":"BeBeez","article_published_time":"2022-11-15T17:00:16+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/"},"author":{"name":"","@id":""},"headline":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V.","datePublished":"2022-11-15T17:00:16+00:00","dateModified":"2022-11-15T17:00:16+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/"},"wordCount":1805,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Private capital in North America"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/","url":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/","name":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V. - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-11-15T17:00:16+00:00","dateModified":"2022-11-15T17:00:16+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/private-capital-in-north-america\/frazier-lifesciences-acquisition-corporation-shareholders-approve-business-combination-with-newamsterdam-pharma-holding-b-v\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Frazier Lifesciences Acquisition Corporation Shareholders Approve Business Combination with NewAmsterdam Pharma Holding B.V."}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/834909","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=834909"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/834909\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=834909"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=834909"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=834909"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=834909"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=834909"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}